Hess, B., Bekker, H., Berendsen, H
The recommended dosage is 1.75mg injected under the skin
Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of chemotherapy (LUX-Lung 1): a phase 2b/3 randomised trial
Christopher Mendias in Medscape (May 1, 2026): treat the peptide conversation like an illicit drug use conversation, eventually moving to a gentle follow-the-money discussion. The evidence base, what physicians need to know before prescribing Before prescribing any of these compounds, you have to articulate clinical reasoning, document the evidence you relied upon including its limitations, and demonstrate informed consent occurred
Already set up with an Empower account?